Weston, MA, United States of America

Elisabeth Hennessy

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 12.5

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):

Title: Innovations by Elisabeth Hennessy

Introduction

Elisabeth Hennessy is a prominent inventor based in Weston, MA (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of small molecule inhibitors for cancer treatment. With a total of six patents to her name, Hennessy is recognized for her innovative approaches to addressing complex medical challenges.

Latest Patents

Hennessy's latest patents focus on small molecule inhibitors of the KRAS G12C mutant. The disclosures provide compounds of Formula (I) or pharmaceutically acceptable salts that can inhibit the G12C mutant of the Kirsten rat sarcoma (KRAS) protein. These compounds are expected to serve as therapeutic agents for treating cancer. The patents also include pharmaceutical compositions that comprise these compounds and methods for their use in therapy and prophylaxis of cancer.

Career Highlights

Elisabeth Hennessy is currently associated with Merck Sharp & Dohme Corporation, where she continues to advance her research and development efforts. Her work has been instrumental in creating innovative solutions that have the potential to improve cancer treatment outcomes.

Collaborations

Hennessy has collaborated with notable colleagues, including Thomas H Graham and Indu T Bharathan. These partnerships have fostered a collaborative environment that enhances the research and development process.

Conclusion

Elisabeth Hennessy is a trailblazer in the field of pharmaceutical innovation, with a focus on developing effective cancer therapies. Her contributions through her patents and collaborations highlight her commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…